News

• National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board
  12/10/2019 / 14:10 - GlobeNewswire
•  
• TRI Pointe Homes Acquires Sites to Build 240 Homes in Two Bay Area Master-Planned Communities
  12/05/2019 / 15:00 - GlobeNewswire
•  
• Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for Treatment of Diabetic Cardiomyopathy at the 16th Annual Global Cardiovascular Clinical Trialist’s Forum (CVCT)
  12/05/2019 / 13:00 - GlobeNewswire
•  
• Splash Wines Kicks Off Its 5th Holiday Season Dedicated to Delivering Quality Wines to Customers’ Doorsteps at Unprecedented Prices
  12/03/2019 / 15:05 - GlobeNewswire
•  
• American Resources Corporation Is Drilling Success From Carbon Rich Mines; Seizes Upon Huge Demand For High-Grade Metallurgical Carbon
  12/03/2019 / 14:08 - Newsfile Corp
•  
• Capital Market Laboratories (CMLviz) One-on-One Interview with Five9 CEO - There is clear ROI to automate a part of the customer service process with artificial intelligence and for Five9 and the potential is huge
  11/25/2019 / 19:01 - GlobeNewswire
•  
• ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer
  11/25/2019 / 07:30 - GlobeNewswire
•  
• Horizon Media Study Finds Instagram’s Move to Hide Likes is Somewhat of a Collective Shrug, but with a Glimmer of Hope
  11/22/2019 / 21:16 - GlobeNewswire
•  
• AIAG and Thomson Reuters Release Second Regional Supply Chain 2025 Report
  11/21/2019 / 16:55 - GlobeNewswire
•  
• Ironwood Capital Announces Sale of Precision Manufacturer Numet Machining Techniques
  11/13/2019 / 18:13 - GlobeNewswire
•  
• FactSet® Launches Workstation on OpenFin
  11/12/2019 / 14:00 - GlobeNewswire
•  
• Woodside Hotel Group Implements Visiting Media’s TrueTour™ Selling Technology Across Full Portfolio of Hotels
  11/08/2019 / 20:55 - GlobeNewswire
•  
• Zephyr Real Estate Sponsors Potrero Festival
  11/08/2019 / 18:00 - GlobeNewswire
•  
• TELUS reports strong operational and financial results for third quarter 2019
  11/07/2019 / 12:45 - GlobeNewswire
•  
• Vyome Therapeutics Completes Enrollment of Phase 2 Clinical Trial with VB-1953 in Moderate to Severe Inflammatory Acne
  11/05/2019 / 13:30 - GlobeNewswire